跳至主要内容
临床试验/NCT02391077
NCT02391077Unknown1 期

A Randomized, Open Label, Two Phase Trial, to Assess Various Antimicrobial Techniques for Reducing Bacterial Load Prior PrePex Removal

Ministry of Health, Rwanda2 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2015年4月最近更新:
适应症

试验速览

阶段
1 期
入组人数
33
试验地点
2
主要终点
The semi quantitative count of bacteria on days 0 and 7

研究概览

简要总结

There is a potential of bacterial overgrowth under the foreskin in the sub-preputial space, therefore we would like to investigate possible techniques to reduce this potential.

详细描述

The PrePex device was accepted for the World Health Organization (WHO) list of prequalified male circumcision (MC) devices and was listed on 31 May 2013.

PrePex became the first medical device for adult male circumcision to receive WHO prequalification as an alternative to the conventional surgical circumcision methods already recognized by WHO.

Voluntary Medical Male Circumcision (VMMC) is a one-time, low cost intervention that shown to reduce men's risk of HIV infection by approximately 70 percent. The WHO recommends VMMC as part of a comprehensive package of HIV prevention services.

The PrePex compresses the foreskin causing ischemic necrosis. Due to the foreskin necrotic state, it is no longer possible for men to fully retract the skin and properly clean the sulcus and inner foreskin, the sub-preputial space normally has a low oxygen environment facilitating anaerobe growth, and following device placement the environment becomes more so leading to a higher bacterial load. This was suggested by reports of unpleasant odor following device placement and confirmed by laboratory test done by RHSP Uganda of swabs taken from inside the foreskin prior to device removal, results not yet published.

There is a potential of bacterial overgrowth under the foreskin in the sub-preputial space, therefore we would like to investigate possible techniques to reduce this potential.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
21 Years 至 49 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Ages - 21 to 49 years
  • Subject wants to be circumcised
  • Uncircumcised
  • Able to understand the study procedures and requirements
  • Agrees to participate in either arm and to follow the hygiene and wound care instructions
  • Agrees to have swab samples
  • Agrees to abstain sexual intercourse for 6 weeks post device removal
  • Agrees to abstain from masturbation for 2 weeks post device removal
  • Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision
  • Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
  • Subject agrees to anonymous video and photographs of the procedure and follow up visits.

排除标准

  • Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
  • Subject with the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
  • Known bleeding / coagulation abnormality, uncontrolled diabetes, by questionnaire
  • Known allergy to Betadin-Iodine
  • Known allergy to antibiotics containing Bacitracin, Neomycin and Polymixin
  • Subject who have an abnormal penile anatomy or any penile diseases
  • Subject that to the opinion of the investigator is not a good candidate
  • Subject does not agree to anonymous video and photographs of the procedure and follow up visits.

结局指标

主要结局

The semi quantitative count of bacteria on days 0 and 7

时间窗: Days 0 and 7

次要结局

  • Placement preparation technique as a measure of reduction of preputial space bacterial load(Day 0)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Vincent Mutabazi

Director of the Research Grants Unit

Ministry of Health, Rwanda

研究点 (2)

Loading locations...

相似试验

A Trial Assessing Efficacy of Various Antimicrobial... | 临床试验